secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytomX Therapeutics, Inc. (CTMX)
CIK:        0001501989
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001193125-23-180722
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytomX raises $30M via private placement of units with warrants
---------------------------------------------------------------

- Gross proceeds of $30M from unit sale at $2.08 each; closing expected July 3, 2023.
- Each unit: 1 share or Pre-Funded Warrant ($0.00001 exercise, 20-yr term) plus Tranche 1 ($4.16, exp. 2025) and Tranche 2 ($6.24, exp. 2026) warrants.
- No underwriter; resale registration statement to be filed within 60 days after closing.
- Pre-funded and Tranche warrants may not be exercised if holder would exceed 9.99% ownership (adjustable to 19.99%).
- Exercise price of Tranche warrants subject to reset if future offering below $4.16, but not below $2.08.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501989/000119312523180722/0001193125-23-180722-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501989/000119312523180722/d500160d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-180722

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer